Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ARG1 | P05089 | 1/20 | 0.53 |
| ▸ | ARG2 | P78540 | 1/20 | 0.53 |
| ▸ | NOS2 | P35228 | 3/20 | 0.52 |
| ▸ | NOS1 | P29475 | 2/20 | 0.52 |
| ▸ | NOS3 | P29474 | 1/20 | 0.52 |
| ▸ | SLC7A5 | Q01650 | 1/20 | 0.50 |
| ▸ | BHMT | Q93088 | 2/20 | 0.47 |
| ▸ | BHMT2 | Q9H2M3 | 1/20 | 0.47 |
| ▸ | SLC1A3 | P43003 | 4/20 | 0.45 |
| ▸ | SLC1A2 | P43004 | 4/20 | 0.45 |
| ▸ | SLC1A1 | P43005 | 3/20 | 0.45 |
| ▸ | KIF11 | P52732 | 5/20 | 0.43 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.42 |
| ▸ | SLC7A11 | Q9UPY5 | 1/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.40 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Alanine SCHEMBL9937851 | 1.00 | ARG1 (0.53) | ARG1ARG2NOS2NOS1NOS3 | |
| Alanine SCHEMBL9937853 | 1.00 | ARG1 (0.53) | ARG1ARG2NOS2NOS1NOS3 | |
| SCHEMBL36934 | 0.90 | ARG1 (0.61) | ARG1ARG2NOS2NOS1NOS3 | |
| SCHEMBL29393779 | 0.90 | ARG1 (0.61) | ARG1ARG2NOS2NOS1NOS3 | |
| SCHEMBL36935 | 0.90 | ARG1 (0.61) | ARG1ARG2NOS2NOS1NOS3 | |
| SCHEMBL29378137 | 0.90 | ARG1 (0.61) | ARG1ARG2NOS2NOS1NOS3 | |
| SCHEMBL36933 | 0.90 | ARG1 (0.61) | ARG1ARG2NOS2NOS1NOS3 | |
| SCHEMBL23085771 | 0.88 | SLC7A5 (0.54) | ARG1ARG2NOS2NOS1NOS3 | |
| SCHEMBL2128359 | 0.88 | SLC7A5 (0.54) | ARG1ARG2NOS2NOS1NOS3 | |
| Hydrogen Sulfide SCHEMBL5666458 | 0.87 | ARG1 (0.59) | ARG1ARG2NOS2NOS1NOS3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2651382-A1 | METHOD FOR PERMANENT RESHAPING AND IN PARTICULAR FOR STRAIGHTENING, COMPRISING A STAGE OF STRAIGHTENING KERATINOUS FIBRES EMPLOYING A COMPOSITION COMPRISING AT LEAST 40% BY WEIGHT OF NON-SILICONE FATTY SUBSTANCES | L'Oréal (FR) | 2013-10-23 | — | — | EP | disclosed |
| WO-2012080231-A1 | METHOD FOR PERMANENT RESHAPING AND IN PARTICULAR FOR STRAIGHTENING, COMPRISING A STAGE OF STRAIGHTENING KERATINOUS FIBRES EMPLOYING A COMPOSITION COMPRISING AT LEAST 40% BY WEIGHT OF NON-SILICONE FATTY SUBSTANCES | L'OREAL (FR) | 2012-06-21 | — | — | WO | disclosed |
| CN-102123723-A | Glucagon/GLP-1 receptor co-agonists | UNIV INDIANA RES & TECH CORP | 2011-07-13 | — | — | CN | disclosed |